Fearing patients would die, a former pharmaceutical rep went undercover for FDA investigators to stop the illegal “off-label” promotion of an opioid lollipop Source
Fearing patients would die, a former pharmaceutical rep went undercover for FDA investigators to stop the illegal “off-label” promotion of an opioid lollipop Source